{
    "2021-12-01": [
        [
            {
                "time": "2021-11-01",
                "original_text": "恒瑞医药现1笔大宗交易 共成交750.32万元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "成交"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-01",
                "original_text": "恒瑞、珍宝岛…纷纷入场，这一市场开始“群雄逐鹿”",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "珍宝岛",
                        "入场",
                        "市场竞争"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-01",
                "original_text": "11月国内13起license in/out，涉及恒瑞医药、再鼎医药、天境生物",
                "features": {
                    "keywords": [
                        "license in/out",
                        "恒瑞医药",
                        "再鼎医药",
                        "天境生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-01",
                "original_text": "恒瑞医药今日大宗交易成交16.60万股，成交价45.2元折价10.5%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "折价"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-01",
                "original_text": "石药、恒瑞频出手 老牌大药企快速切入“买买买”模式",
                "features": {
                    "keywords": [
                        "石药",
                        "恒瑞",
                        "买买买",
                        "模式"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-01",
                "original_text": "3200亿创新药巨头突收监管函，恒瑞医药回应称涉及会计政策 询问",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "监管函",
                        "会计政策"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "A股融资融券日报：两融余额增加15.02亿元（11月30日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "交易所向恒瑞医药发出监管工作函 对会计政策明确具体要求",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "监管工作函",
                        "会计政策"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "周三证券 | 变异毒株阴影下 优选医药细分龙头",
                "features": {
                    "keywords": [
                        "变异毒株",
                        "医药",
                        "细分龙头"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}